Revathi Govind

Revathi Govind is a Professor in the Division of Biology at Kansas State University, specializing in Clostridioides difficile pathogenesis research. Her work focuses on the molecular mechanisms of bacterial virulence, particularly in cancer patients undergoing chemotherapy, where C. difficile infections complicate treatment outcomes.

• Ph.D. in Microbiology & Immunology from Texas Tech University (2006)
• Director of research programs studying regulatory pathways linking sporulation and toxin production
• Investigator of carbohydrate metabolism's role in bacterial colonization

Research keywords include: Pathogenic Microbiology, Bacterial Genetics, and Hospital-Acquired Infections. Current projects examine:

• Glycogen metabolism's contribution to spore resilience
• Signal transduction pathways in virulence regulation
• Development of diagnostic tools and therapeutic agents

Recent publications span 2013-2024 with significant contributions in:

• Regulatory networks of C. difficile
• SinR/SinI protein interaction systems
• Carbohydrate-mediated virulence factors

Scientific awards include:

• NIH R21 grant for variant analysis
• Cancer Research Expansion Award
• Rhabdomyosarcoma Research Award